Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252577 · ClinicalTrials.gov registry record
Genetic Predictors of Lithium Response in Bipolar Disorder
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 130
- Enrollment target
NCT00252577: Completed study, sponsored by VA Office of Research and Development.
NCT00252577 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00252577 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
The purpose of this study is to identify genetic predictors of lithium response in bipolar disorder.
Primary Outcome
The primary outcome measure was time to relapse in months following stabilization on lithium.
Interventions
- DRUG Lithium treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2005-10 |
| Est. Completion | 2016-05 |
What the finished NCT00252577 record still lists
NCT00252577 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Lithium treatment is the first listed.
NCT00252577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00252577 about?
NCT00252577 is a clinical study titled "Genetic Predictors of Lithium Response in Bipolar Disorder". The purpose of this study is to identify genetic predictors of lithium response in bipolar disorder.
What is the current status of trial NCT00252577?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2005-10. Estimated completion is 2016-05.
What interventions are being tested in trial NCT00252577?
The interventions under investigation include: Lithium treatment (DRUG).
Who is sponsoring clinical trial NCT00252577?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia